Effect of the LumbaCure® Intervention on Elderly Patients Suffering From cLBP.

NCT ID: NCT06203886

Last Updated: 2024-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-11

Study Completion Date

2024-07-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this investigation is to evaluate the safety and efficacy of the LumbaCure® device in elderly people suffering from low back pain. The study is being carried out at several sites, in nursing homes, in order to reach the elderly patients most at risk of a sedentary lifestyle.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test Intervention arm

LumbaCure robotic device

Group Type EXPERIMENTAL

LumbaCure

Intervention Type DEVICE

LumbaCure® is a device developed to induce specific mobilization of the lower back in patients requiring physical rehabilitation for orthopaedic disorders, particularly chronic low back pain.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LumbaCure

LumbaCure® is a device developed to induce specific mobilization of the lower back in patients requiring physical rehabilitation for orthopaedic disorders, particularly chronic low back pain.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronic or sub-acute low back pain (without "red flag")
* The subject, a resident or worker at the investigation site (nursing home), over 60 years of age
* Ability to communicate with the physiotherapist.
* Ability to remain in a sitting position for at least 10 minutes.
* A level of back pain \> 2 on the numerical pain rating scale

Exclusion Criteria

* Suspected or confirmed serious pathology (infection, fracture, cancer, inflammatory arthritis, ....) related to the back/spine.
* Body weight \> 120 kg
* Subject is non-ambulatory or has severely reduced mobility.
* Dominant component of radicular pain (common lumbago with distal radiation below the knee)
* Radiculopathy
* Severe cardiorespiratory disease
* Dementia or significant cognitive impairment that prevents the participant from giving consent, completing study questionnaires or complying with recommendations.
* Fracture or operation less than 3 months old of the spine, pelvis, hip or leg bones.
* Known vertebral pathology other than osteoarthritis.
* Major neurological disease, movement or motor neuron disorders
* Fibromyalgia or other systemic rheumatic disease
* Recent history of stroke or heart failure, unstable heart condition
* Uncontrolled substance abuse disorders
* Invasive procedures to relieve pain in the last 3 months
* Acute or terminal illness
* Any other medical condition considered by the study team to be a contraindication to the study.
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Odix

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ASBL " Mère Joséphine " - MRS Saint Joseph Blegny

Blégny, Liège, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIV-23-09-043961

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.